Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022

Merkel cell carcinoma (MCC) is a rare skin cancer, accounting for less than 1% of all cutaneous malignancies. It is found predominantly in white populations and risk factors include advanced age, ultraviolet exposure, male sex, immunosuppression, such as AIDS/HIV infection, haematological malignanci...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) Jg. 171; S. 203 - 231
Hauptverfasser:	Gauci, Marie-Léa, Aristei, Cynthia, Becker, Jurgen C., Blom, Astrid, Bataille, Veronique, Dreno, Brigitte, Del Marmol, Veronique, Forsea, Ana M., Fargnoli, Maria C., Grob, Jean-Jacques, Gomes, Fabio, Hauschild, Axel, Hoeller, Christoph, Harwood, Catherine, Kelleners-Smeets, Nicole, Kaufmann, Roland, Lallas, Aimilios, Malvehy, Josep, Moreno-Ramirez, David, Peris, Ketty, Pellacani, Giovanni, Saiag, Philippe, Stratigos, Alexander J., Vieira, Ricardo, Zalaudek, Iris, van Akkooi, Alexander C.J., Lorigan, Paul, Garbe, Claus, Lebbé, Céleste
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Oxford Elsevier Ltd 01.08.2022 Elsevier Science Ltd Elsevier
Schlagworte:	Antibodies Biopsy Blood cancer Cancer Cancer therapies Chemotherapy Clinical trials Consensus Diagnosis Dissection EDF Guidelines Histopathology HIV Human immunodeficiency virus Immunohistochemistry Immunosuppression Immunotherapy Infections Life Sciences Lymph nodes Lymphatic system MCC Medical diagnosis Medical prognosis Merkel cell Metastases Metastasis p53 Protein Patients Protein structure Radiation Radiation therapy Retina Retinoblastoma Retinoblastoma protein Risk analysis Risk factors Sexually transmitted diseases Skin cancer STD Structure-function relationships Survival Transplantation Tumors MCC Merkel cell EDF Consensus Guidelines
ISSN:	0959-8049, 1879-0852, 1879-0852
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!